
CPHI & PMEC China 2026
06/2026 – 06/2026
Qiyuan Pharma mainly concentrates on manufacturing active pharmaceutical ingredients including erythromycin base, erythromycin thiocyanate, tetracycline hydrochloride, tetracycline base, azithromycin, clarithromycin and vitamin products. With a technology advantage and superior quality, the company's materials enjoy a strong reputation worldwide, widely exported to South America, North America, Latin America, Europe, Africa and Asia; the company is the world's largest manufacturer of erythromycin and tetracycline hydrochloride, with its tetracycline hydrochloride US FDA and CoS approved.

Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen